Effect of the prebiotics taken by pregnant and lactating women on the immunoactive substance in the breast milk and bowel movement
Not Applicable
- Conditions
- pregnant woman
- Registration Number
- JPRN-UMIN000008142
- Lead Sponsor
- Graduate School of Medicine, Chiba University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1. The pregnant woman who need whole body control for toxemia of pregnancy or other diseases during pregnancy progress. 2. The pregnant woman who were judged to be unsuitable from efficacy and safety by doctor.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method cytokines, IgA and sCD14 in breastmilk
- Secondary Outcome Measures
Name Time Method 1. Specific and non specific IgE in mother's blood and umbilical cord blood. 2. Profile of gene expression in white blood cells in breastmilk 3. Changes in bowel habit 4. Changes in intestinal flora of mothers 5. Existence of allergic diseases of chilren at the age of six month